Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erysipelas.

The Antiseptic·2010
Same author

Tetanus; its treatment.

The Antiseptic·2010
Same author

Why life is a failure? A psychological study.

Indian medical record·2010
Same author

Tropical eosinophilia.

The Antiseptic·2010
Same author

Injuries from lightning.

The Antiseptic·2010
Same author

Double fractures of AO intramedullary femoral nails.

Injury·1989
Same journal

A case of quinine allergy.

The Antiseptic·2010
Same journal

Efficacy of nicotinic acid in ear troubles.

The Antiseptic·2010
Same journal

An unusual case of diabetes mellitus.

The Antiseptic·2010
Same journal

Importance of primary disinfection in wounds caused by dog-bite.

The Antiseptic·2010
Same journal

A bad case of status epilepticus.

The Antiseptic·2010
Same journal

A case of abnormal permeability of retinal vessels.

The Antiseptic·2010
See all related articles

Related Experiment Video

Updated: Jun 14, 2026

In vitro tRNA Methylation Assay with the Entamoeba histolytica DNA and tRNA Methyltransferase Dnmt2 (Ehmeth) Enzyme
12:36

In vitro tRNA Methylation Assay with the Entamoeba histolytica DNA and tRNA Methyltransferase Dnmt2 (Ehmeth) Enzyme

Published on: October 19, 2010

Emetine in amoebiasis

B M SINHA

    The Antiseptic
    |March 19, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    AMEBIASIS/therapy

    More Related Videos

    Development of a Negative Selectable Marker for Entamoeba histolytica
    06:05

    Development of a Negative Selectable Marker for Entamoeba histolytica

    Published on: December 12, 2010

    Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection
    11:49

    Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection

    Published on: June 12, 2014

    Related Experiment Videos

    Last Updated: Jun 14, 2026

    In vitro tRNA Methylation Assay with the Entamoeba histolytica DNA and tRNA Methyltransferase Dnmt2 (Ehmeth) Enzyme
    12:36

    In vitro tRNA Methylation Assay with the Entamoeba histolytica DNA and tRNA Methyltransferase Dnmt2 (Ehmeth) Enzyme

    Published on: October 19, 2010

    Development of a Negative Selectable Marker for Entamoeba histolytica
    06:05

    Development of a Negative Selectable Marker for Entamoeba histolytica

    Published on: December 12, 2010

    Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection
    11:49

    Analysis of the Epithelial Damage Produced by Entamoeba histolytica Infection

    Published on: June 12, 2014